Tocolytic drugs ineffective for premature birth after 30 weeks

FHS
March 4, 2025
3:12 am

The use of tocolytic drugs in cases of threatened premature birth after 30 weeks of pregnancy does not improve the baby’s health.

PI3K/AKT and MEK/ERK pathways targeted in new therapy for docetaxel-resistant prostate cancer

A team of researchers from the Badalona Applied Research Group in Oncology (B·ARGO) and the Urologic Tumours Unit of the Institut Català d’Oncologia (ICO) and

February 5, 2024

Daylight saving time debate: A critique unveils flaws in mortality study

Researchers critique a study on daylight saving time (DST) and mortality in Europe, highlighting flaws in statistical analysis and the conclusions, arguing the original findings

March 6, 2024

Creating Access To Psychedelic Treatment | Interview with Therapsil’s Yasmeen deRosenroll

November 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.